fromThe American Conservative
1 month agoThe FTC Has the Chance to Rein in Big Pharma
Big Pharma's actions regarding necessary medicines, particularly semaglutide, require careful regulation.
Reliance on two manufacturers for crucial diabetes and obesity drugs poses significant risks to patients.